Based on 110 hedge funds · latest filing: 2025 Q4 · updated quarterly
📈
Buying streak — 6 quarters in a row
For 6 consecutive quarters, more hedge funds added BIOA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️
At the ownership peak (100% of max)
100% of all-time peak
110 hedge funds hold BIOA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀
Fast accumulation — +77% more funds vs a year ago
fund count last 6Q
+48 new funds entered over the past year (+77% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢
More buyers than sellers — 68% buying
69 buying32 selling
Last quarter: 69 funds were net buyers (29 opened a brand new position + 40 added to an existing one). Only 32 were sellers (23 trimmed + 9 sold completely). A clear majority buying is a strong confirmation signal.
📈
More new buyers each quarter (+16 vs last Q)
new funds entering per quarter
Funds opening a new BIOA position: 15 → 25 → 13 → 29. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔄
Mostly new holders — 47% entered in last year
■ 4% conviction (2yr+)
■ 49% medium
■ 47% new
Only 4 funds (4%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💎
Buying through price weakness — shares +10%, value -75%
Last quarter: funds added +10% more shares while total portfolio value only changed -75%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️
Steady discovery — ~29 new funds/quarter
35 → 15 → 25 → 13 → 29 new funds/Q
New funds entering each quarter: 15 → 25 → 13 → 29. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🌱
Early stage — 69% of holders entered in last year
■ 6% veterans
■ 24% 1-2yr
■ 69% new
Of 111 current holders: 77 (69%) entered in the past year, only 7 (6%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
📋
Smaller funds dominant — 19% AUM from top-100
19% from top-100 AUM funds
22 of 110 holders rank in the top 100 by AUM, but together hold only 19% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
5.1
out of 10
Moderate Exit Risk
Exit risk score 5.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.